hematologi
REFERENSER
LB2604: GLOBAL PIVOTAL PHASE 2 TRIAL
OF THE CD19-TARGETED THERAPY CTL019
nelli, Simon Durrant, Christopher Larry Bacon, Kun Nie, Zachary Zimmerman, Hagop
Kantarjian
IN ADULT PATIENTS WITH RELAPSED OR
S410: CARFILZOMIB-LENALIDOMIDEDEXAMETHASONE VS CARFILZOMIBCYCLOPHOSPHAMIDE-DEXAMETHASONE INDUCTION: PLANNED INTERIM ANA-
REFRACTORY (R/R) DIFFUSE LARGE B-CELL
S103: PHASE I, OPEN-LABEL TRIAL OF
LYMPHOMA (DLBCL)AN INTERIM ANALYSIS
ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR
